pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›alisertib
drug · small molecule
save

alisertib

Phase 2updated 3mo ago
by $PBYI PUMA BIOTECHNOLOGY, INC.🔗 ChEMBL
Phase 2
community read0 votes

Small molecule drug with a maximum clinical stage of Phase 3 (across all indications), with 19 investigational indications.

targets

Aurora kinase A

all catalysts(0)

nothing on the calendar yet

Trials studying alisertib

  • phase2A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancerrecruitingn=225
  • phase2Phase 2 Study of Alisertib Therapy for Rhabdoid Tumorsactive not recruitingn=125
  • phase2A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC)not yet recruitingn=50
  • phase2A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancerrecruitingn=80
  • phase2Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancercompletedn=9
  • phase1Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomascompletedn=17
  • phase2Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancercompletedn=169
  • phase1Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancerrecruitingn=38
more trials →

News(0)

no news has mentioned this drug yet

generic
alisertib
MOA
Serine/threonine-protein kinase Aurora-A inhibitor
indication
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
phase
phase_2
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 35m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?